FMXVF yields 6022.28% · JNJ yields 2.14%● Live data
📍 FMXVF pulled ahead of the other in Year 1
Combined, FMXVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FMXVF + JNJ for your $10,000?
Amilot Capital Inc., a mineral resource company, acquires, explores for, develops, and exploits mineral properties in Canada and Colombia. It primarily explores for gold deposits. The company holds interest in the ANCAL property that includes 32 mining concessions, exploitation licenses, and applications covering an area of approximately 21,382 hectares situated in the Marmato/Caramanta districts in Colombia. It also holds interests in the NORTOL property, which consists of 29 mining concessions and applications covering an area of approximately 39,546 hectares located in Tolima district in Colombia; and the Papayo property that comprises approximately 400 meters of galleries covering an area of approximately 15,000 square meters located in the Tolima district in Colombia. The company was formerly known as Tolima Gold Inc. and changed its name to Amilot Capital Inc. in January 2019. The company is based in Toronto, Canada.
Full FMXVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.